Funding for this research was provided by:
a study on serum proteomics and clinical application of pregnancy induced hypertension based on iTRAQ technology (SB201901087)
relationship between fibronectin and hypertensive disorder complicating pregnancy and its clinical application (192102310335)
Article History
Received: 4 March 2022
Accepted: 15 August 2022
First Online: 24 September 2022
Declarations
:
: The research protocol was approved by the Ethical Committee of the Henan Provincial People’s Hospital (Zhengzhou, Henan, China). Written informed consent was collected from all participants before the procedure. All the animal experiment procedures were approved by the Animal Ethics Committee of Henan Provincial People’s Hospital (Zhengzhou, Henan, China).
: The informed consent was obtained from study participants.
: The authors declare no conflict of interest.